FDA, Drugmakers Urge 5th Circ. To Allow Abortion Pill By Mail

By Hailey Konnath

The U.S. Food and Drug Administration and the makers of the abortion medication mifepristone have urged the Fifth Circuit not to reinstate an in-person dispensing requirement, arguing that doing so would disrupt the government's ongoing review of the drug, "threaten chaos" and defy the U.S. Supreme Court.

5 documents attached | Read full article » | Save to favorites »

Ropes & Gray, Latham Steer $3.8B Eli Lilly Mental Health Deal

By Al Barbarino

Eli Lilly said Thursday it will acquire New York-based drug developer AtaiBeckley Inc. in a deal valued at up to $3.8 billion, expanding its pipeline of experimental treatments for depression and other mental health disorders.

Read full article » | Save to favorites »

Pharma Co. Beats Investor Suit Over Prostate Drug Trial

By Sydney Price

A Wisconsin federal judge ruled Wednesday that investors of prostate cancer treatment developer Essa Pharma Inc. have not shown they were misled by the company on the efficacy of its lead drug candidate, which was not as effective as an existing treatment for certain cancer patients in a terminated clinical trial.

Order attached | Read full article » | Save to favorites »

Senate Democrats Revive Bill To End Federal Marijuana Ban

By Sam Reisman

Senate Democrats on Thursday once again reintroduced a cannabis legalization bill that would remove the drug entirely from the ambit of the Controlled Substances Act and impose a tax-and-regulate scheme akin to what is currently in place for alcohol and tobacco.

2 documents attached | Read full article » | Save to favorites »

USTR Broadens Exemptions Ahead Of 25% Brazil Tariff

By Dylan Moroses

A 25% tariff on Brazilian goods will begin next week with an expanded exemption list following public comments on the action, U.S. Trade Representative Jamieson Greer announced.

Notice attached | Read full article » | Save to favorites »

Brief

DEA Judge Lays Out Next Steps Following End Of Pot Hearing

By Sam Reisman

A U.S. Drug Enforcement Administration administrative law judge has laid out upcoming deadlines following the conclusion of hearings on a proposal to move marijuana to Schedule III under the Controlled Substances Act.

Order attached | Read full article » | Save to favorites »

Brief

Diagnostics Co. Labcorp Settles FCA Claims For $14.5M

By Julie Manganis

Diagnostics testing company Labcorp will pay $14.5 million to settle False Claims Act allegations that it submitted unnecessary Medicare claims for urine drug tests, the Massachusetts U.S. attorney's office announced.

Settlement attached | Read full article » | Save to favorites »

Walgreens Sues Mass. Medicaid Program Over Drug Rates

By Julie Manganis

Walgreens says administrators of the Massachusetts Medicaid program cannot rely on drug prices negotiated with pharmacy benefit managers to determine reimbursement rates, in a challenge to the state's effort to claw back $242,000 in alleged overpayments.

Complaint attached | Read full article » | Save to favorites »

Fed. Circ. Vacates $12.7M Copyright Award Against Gov't

By Ivan Moreno

The Federal Circuit on Thursday vacated a $12.7 million copyright award against the federal government over unauthorized copies of software for a project on military health records, holding that the trial judge improperly relied on the project's later cancellation and awarded enhanced damages for willful infringement against the government.

Opinion attached | Read full article » | Save to favorites »

Fed. Circ. Asked Not To Shift Moderna Vax Patent Case To Gov't

By Ryan Davis

Drugmakers like Novartis, former federal judges, a startup group and others have urged the Federal Circuit to reject calls to shift liability in a COVID-19 vaccine patent suit against Moderna to the federal government, saying that doing so would undermine patent rights.

6 documents attached | Read full article » | Save to favorites »

Series

Being A Magician Makes Me A Better Lawyer

The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

Read full article » | Save to favorites »

How Competitive Is Your Compensation? Take Our Survey

Is your compensation keeping pace with the rate of inflation? Do you know what your colleagues made last year? Help Law360 Pulse answer these questions and more in this year's Law Firm Compensation Survey.

Read full article » | Save to favorites »

Feature

As Law Firms Race To Adopt AI, Cost Concerns Grow

By Phillip Bantz

Pressure is mounting on law firm leaders to dive into the AI waters or watch competitors swim away, but figuring out responsible, cost-effective methods to use high-priced legal tech remains tricky, experts say.

Read full article » | Save to favorites »

Richards Layton Apologizes For AI Errors In Chancery Case

By Rose Krebs

Richards Layton & Finger PA and one of its attorneys have apologized to the Delaware Chancery Court for submitting a filing with errors generated by artificial intelligence, asking that sanctions not be imposed.

2 documents attached | Read full article » | Save to favorites »

McDermott Atty Denies Pressuring Friend To Alter Testimony

By Rose Krebs

A McDermott Will & Schulte LLP attorney has told a Delaware vice chancellor that he is in "complete shock" and "hurt" by a longtime friend's contention that he pressured him to change his testimony in a Chancery Court case, saying the accusation "is false and without any merit."

2 documents attached | Read full article » | Save to favorites »

Simpson Thacher 'Never' Explained Ill-Fated Deal, Exec Says

By Cara Salvatore

A founder seeking over $100 million from Simpson Thacher & Bartlett over a transaction he says destroyed his insurance services company testified Thursday the law firm provided him no education on various words he wasn't familiar with in the deal.

Read full article » | Save to favorites »

Blue-Slip-Backed Trump Judge Selections Advance

By Courtney Bublé

The first two judicial nominations of the second Trump administration to receive supportive blue slips from Democratic senators advanced to the Senate floor Thursday.

Read full article » | Save to favorites »

Goulston Docked Ex-Partners' Pay For Joining Rival, Suit Says

By Julie Manganis

Two Goulston & Storrs PC directors who jumped to Troutman Pepper Locke LLP were stiffed out of hundreds of thousands of dollars in compensation in retaliation for leaving, according to a suit filed Thursday in New York federal court.

Complaint attached | Read full article » | Save to favorites »

Feature

In Uber Assault Trial, A Courtroom Tests Truth Face-To-Face

By Hayley Fowler

This is the first in a two-part series about the Virginia Revival Model courtroom in the Charles R. Jonas federal courthouse in Charlotte, North Carolina. Here, judges and attorneys recall how a sexual assault trial against Uber unfolded in a space designed to place focus on the witnesses.

Read full article » | Save to favorites »

Tillis Might Back Blanche, As AG Pick Met Epstein Survivors

By Courtney Bublé

Acting U.S. Attorney General Todd Blanche on Thursday afternoon met with a group of survivors of sex offender Jeffrey Epstein after retiring Sen. Thom Tillis, R-N.C., said his condition for supporting Blanche's appointment to the permanent position was for the nominee to speak to them face-to-face.

Read full article » | Save to favorites »